beta-lactams has been researched along with Cystitis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassisa, V; Chenouard, R; Eveillard, M; Kempf, M; Lemarié, C; Pailhoriès, H | 1 |
| Naber, KG; Wagenlehner, FME | 1 |
| Arakawa, S; Hamasuna, R; Hayami, H; Kiyota, H; Kobayashi, K; Matsumoto, T; Takahashi, S; Tanaka, K; Yamamoto, S; Yasuda, M | 1 |
| Fujii, S; Fujino, K; Hashimoto, J; Hiyama, Y; Ichihara, K; Masumori, N; Shinagawa, M; Takahashi, S; Uehara, T | 1 |
| Boisseau, D; Ferry-Blanco, C; Forestier, E; Gros, S; Labe, A; Lecomte, C; Levast, M; Peynaud, D; Rogeaux, O | 1 |
| Fariñas, MC; García-Palomo, D; Horcajada, JP | 1 |
| Balbinot, A; Catavitello, C; D'Antonio, D; Di Berardino, F; Di Bonaventura, G; Di Zacomo, S; Esattore, F; Favaro, M; Febbo, F; Fontana, C; Manna, A; Pompetti, F; Savini, V; Talia, M | 1 |
| Akatsuka, K; Chimura, T; Funayama, T; Hayashi, Y; Hirayama, T; Kaneko, N; Morisaki, N; Murayama, K; Numazaki, M; Oda, T; Sato, F | 1 |
| Baker, P; Greenwood, D; O'Grady, F | 1 |
| Hirano, S; Hisazumi, H; Ohkawa, M; Orito, M; Shimamura, M; Yamaguchi, K | 1 |
1 review(s) available for beta-lactams and Cystitis
| Article | Year |
|---|---|
[Treatment of uncomplicated lower urinary tract infections].
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fosfomycin; Humans; Nitrofurantoin; Practice Guidelines as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2005 |
2 trial(s) available for beta-lactams and Cystitis
| Article | Year |
|---|---|
Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cystitis; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Time Factors; Treatment Outcome; Young Adult | 2014 |
[Clinical studies of faropenem in the field of obstetrics and gynecology].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cystitis; Female; Genital Diseases, Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lactams; Mastitis; Middle Aged; Pelvic Inflammatory Disease; Uterine Cervicitis; Uterine Diseases | 1999 |
7 other study(ies) available for beta-lactams and Cystitis
| Article | Year |
|---|---|
Staphylococcus saprophyticus: Which beta-lactam?
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cystitis; Drug Resistance, Multiple, Bacterial; Empirical Research; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyelonephritis; Staphylococcus saprophyticus; Urinary Tract Infections; Young Adult | 2017 |
Novel Antibiotics in the Treatment of Urinary Tract Infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cystitis; Drug Resistance, Bacterial; Drug Therapy, Combination; Drug Utilization; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Iatrogenic Disease; Tetracyclines; Urinary Tract Infections | 2019 |
The efficacy of faropenem for patients with acute cystitis caused by extended spectrum β-lactamase producing Escherichia coli.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cystitis; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Young Adult | 2017 |
[Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriacea].
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cystitis; Drug Evaluation; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prostatitis; Pyelonephritis; Recurrence; Retrospective Studies; Risk Factors | 2012 |
Multidrug-resistant Escherichia fergusonii: a case of acute cystitis.
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Cystitis; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Urine | 2008 |
An in vitro evaluation of clavulanic acid, a potent, broad-spectrum beta-lactamase inhibitor.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cystitis; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Humans; Models, Biological; Nephelometry and Turbidimetry; Penicillin Resistance | 1979 |
[Detection of beta-lactamase-producing bacteria from female patients with acute uncomplicated cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Child; Cystitis; Drug Resistance, Microbial; Female; Humans; Middle Aged | 1987 |